Current News

2017

MyoKardia

March 17, 2017 - MyoKardia Appoints Kim Popovits and Wendy Yarno to Board of Directors                                                                                        View PDF 

March 13, 2017 - MyoKardia Reports Fourth Quarter and Full Year 2016 Financial Results and Operational Progress                                                        View PDF 

February 2, 2017 - First Subjects Dosed in Phase 1 Study of Dilated Cardiomyopathy Candidate MYK-491                                                                  View PDF 

January 3, 2017 - MyoKardia Announces Advancement to Next Phase of Global Collaboration with Sanofi                                                                  View PDF 

2016

MyoKardia

December 2, 2016 - MyoKardia Announces Receipt of Milestone Payment from Sanofi for DCM Candidate MYK-491

View PDF 

December 1, 2016 - MyoKardia Announces Appointment of Marc Semigran, M.D., as Chief Medical Officer

View PDF 

 Warp Drive Bio

November 29, 2016 - Warp Drive Bio Achieves Key Milestone in Antibiotics Collaboration with Sanofi 

View PDF

 MyoKardia

November 11, 2016 - MyoKardia Announces Exploratory Digital Health Substudy as Part of PIONEER-HCM Trial of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients

View PDF 

November 7, 2016 - MyoKardia Reports Progress on Clinical Programs and Third Quarter 2016 Financial Results                                                      View PDF

November 2, 2016 - MyoKardia Announces Dosing of First Patient in Phase 2 PIONEER-HCM Study of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy 

View PDF 

September 21, 2016 - MyoKardia Outlines Path to Registration for MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients and Provides Pipeline and Research Updates at Inaugural R&D Day

 View PDF

 

Warp Drive Bio

August 30, 2016 - Warp Drive Bio Awarded Patent Covering Proprietary Method for Discovering New Medicines

View PDF 

 

MyoKardia

July 11, 2016 - MyoKardia Announces Topline Clinical Data Supporting Advancement of MYK-461 to Phase 2 Pioneer-HCM study in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients

View PDF 

MyoKardia

June 1, 2016 - Study of SHaRE Data Published in PNAS Demonstrates the Power of Combining Clinical, Genetic, and Structural Data to Gain Insight into HCM

View PDF 

May 2, 2016- MyoKardia Receives Orphan Drug Designation for MYK-461 for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

View PDF 

April 13, 2016- MyoKardia Names Mary Cranston to Board of Directors

View PDF 

Warp Drive Bio

April 6, 2016 - Warp Drive Bio Appoints Alan C. Rigby, Ph.D., as Chief Scientific Officer

View PDF 

 

DiCE

March 16, 2016 - Sanofi and DiCE Molecules Announce Research Collaboration to Discover Potential Therapeutics Based on Unique Small Molecule Discovery Platform  

View PDF 

MyoKardia

February 4, 2016 - MyoKardia Publishes Article in Science Demonstrating That MYK-461 Prevents and Reverses Disease in Genetic Mouse Models of Hypertrophic Cardiomyopathy

View PDF  

Warp Drive Bio

January 11, 2016 - Sanofi and Warp Drive Bio to Collaborate on the Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms 

View PDF 

 

2015

Warp Drive Bio

November 9, 2015 - Warp Drive Bio Announces Breakthrough in the Ability to Target the Previously Undruggable Oncogene RAS

View PDF 

Warp Drive Bio

November 9, 2015 - Warp Drive Bio Announces Formation of Board of World-Leading Oncology Experts to Focus on Company’s RAS Program

 View PDF 

MyoKardia

November 4, 2015 - MyoKardia Announces Presentations at American Heart Association Scientific Sessions 2015

View PDF

MyoKardia

November 3, 2015 - MyoKardia Announces Closing of Initial Public Offering

View PDF

MyoKardia

October 28, 2015 - MyoKardia Announces Pricing of Initial Public Offering

View PDF

Portal Instruments

 October 20, 2015 - Portal Instruments Closes a $25 Million Series B Financing to Commercialize its Transformative Needle-Free Drug Delivery System

View PDF

MyoKardia

 October 14, 2015 - MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors

View PDF

MyoKardia

 October 6, 2015 - MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy

View PDF

MyoKardia

 September 30, 2015 - FierceBiotech names MyoKardia as one of its “Fierce 15” Biotech Companies of 2015

View PDF

MyoKardia

 April 30, 2015 - MyoKardia, Inc. Completes $46 Million Series B Financing

View PDF

Warp Drive Bio

March 4, 2015 - Warp Drive Bio Appoints Industry Veteran Laurence Reid, Ph.D., to Chief Executive Officer

View PDF